Fennec Pharmaceuticals (FENC) Research & Development (2010 - 2026)

Fennec Pharmaceuticals (FENC) has 16 years of Research & Development data on file, last reported at $18.4 million in Q4 2025.

• Quarterly Research & Development rose 366.18% year-over-year to $18.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $26.6 million (up 101.59% YoY) and the FY2025 annual result came in at $18.6 million, up 1.03% from the prior year.
• Research & Development climbed to $18.4 million in Q4 2025, from $5.2 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $18.4 million in Q4 2025 to a low of $3000.0 in Q1 2024.
• A 5-year average of $2.6 million and a median of $1.2 million in 2021 frame the typical range for Research & Development.
• Annual changes were most pronounced in 2023 — Research & Development tumbled 99.72% — and 2025, when it soared 98133.33%.
• Tracing FENC's Research & Development over 5 years: stood at $523000.0 in 2021, then plunged by 77.63% to $117000.0 in 2022, then slumped by 72.65% to $32000.0 in 2023, then jumped by 12225.0% to $3.9 million in 2024, then jumped by 366.18% to $18.4 million in 2025.
• The last three Research & Development figures came in at $18.4 million (Q4 2025), $5.2 million (Q3 2025), and $107000.0 (Q2 2025), per Business Quant data.